Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

CTTHWGFTLC peptide

Known as: CTT1 peptide, CTTHWGFTLC 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.
Following myocardial infarction (MI), degradation of extracellular matrix (ECM) by upregulated matrix metalloproteinases (MMPs… 
2014
2014
Systemic Delivery of Protein Nanocages Bearing CTT Peptides for Enhanced Imaging of MMP-2 Expression in Metastatic Tumor Models
Matrix metalloproteinase 2 (MMP-2) in metastatic cancer tissue, which is associated with a poor prognosis, is a potential target… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2010
Highly Cited
2010
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration
The cannabinoid receptor 2 (CB2) plays a pleiotropic role in innate immunity and is a crucial mediator of liver disease. In this… 
2007
2007
Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia.
This study was carried out to determine the role of increased vascular matrix metalloproteinase-2 (MMP-2) expression in the… 
Highly Cited
2006
Highly Cited
2006
In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models.
INTRODUCTION Overexpression of matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, has been correlated with poor… 
  • figure 1
  • table 1
  • figure 3
  • table 2
  • figure 4
Highly Cited
2005
Highly Cited
2005
Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.
Tumors express MMP-2 and MMP-9 gelatinases, which are involved in the formation of tumor vasculature. This suggests that a tumor… 
Highly Cited
2002
Highly Cited
2002
Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and…
Bisphosphonates (clodronate, alendronate, pamidronate and zoledronate) at therapeutically attainable non-cytotoxic concentrations… 
Highly Cited
2001
Highly Cited
2001
Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro.
We have recently described a novel cyclic peptide inhibitor CTTHWGFTLC (CTT) for matrix metalloproteinases (MMP)-2 and MMP-9… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2000
Highly Cited
2000
Vascular Matrix Metalloproteinase-2–Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction
Matrix metalloproteinase (MMP)-2 has been historically associated with the process of vascular remodeling through the cleavage of… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1999
Highly Cited
1999
Tumor targeting with a selective gelatinase inhibitor
Several lines of evidence suggest that tumor growth, angiogenesis, and metastasis are dependent on matrix metalloproteinase (MMP… 
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE